A Cost-Per-Responder Analysis of Secukinumab Compared with Ustekinumab in Saudi Arabia- Results from the Clear Study of Patients With Moderate to Severe Psoriasis
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.808
https://www.valueinhealthjournal.com/article/S1098-3015(18)33165-6/fulltext
Title :
A Cost-Per-Responder Analysis of Secukinumab Compared with Ustekinumab in Saudi Arabia- Results from the Clear Study of Patients With Moderate to Severe Psoriasis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33165-6&doi=10.1016/j.jval.2018.07.808
First page :
Section Title :
Open access? :
No
Section Order :
43